Literature DB >> 31982152

A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort study.

Max J Gordon1, Andrea Sitlinger2, Tareq Salous2, Hamood Alqahtani2, Michael Churnetski2, Xavier Rivera2, Paul Wisniewski2, Jonathon Cohen2, Krish Patel2, Mayzar Shadman2, Michael Choi2, Brian Hill2, Deborah Stephens2, Daniel Persky2, Danielle Brander2, Alexey V Danilov3.   

Abstract

Entities:  

Keywords:  Chronic lymphocytic leukemia; Ibrutinib; Prognostic index

Mesh：

Substances：

Year:  2020        PMID： 31982152     DOI： 10.1016/j.leukres.2020.106302

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  2 in total

1.  Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data

Authors:  Anıl Tombak; Funda Pepedil Tanrıkulu; Salih Sertaç Durusoy; Hüseyin Derya Dinçyürek; Emin Kaya; Elif Gülsüm Ümit; İrfan Yavaşoğlu; Özgür Mehtap; Burak Deveci; Mehmet Ali Özcan; Hatice Terzi; Müfide Okay; Nilgün Sayınalp; Mehmet Yılmaz; Vahap Okan; Alperen Kızıklı; Ömer Özcan; Güven Çetin; Sinan Demircioğlu; İsmet Aydoğdu; Güray Saydam; Eren Arslan Davulcu; Gül İlhan; Mehmet Ali Uçar; Gülsüm Özet; Seval Akpınar; Burhan Turgut; İlhami Berber; Erdal Kurtoğlu; Mehmet Sönmez; Derya Selim Batur; Rahşan Yıldırım; Vildan Özkocamaz; Ahmet Kürşad Güneş; Birsen Sahip; Şehmus Ertop; Olga Meltem Akay; Abdülkadir Baştürk; Mehmet Hilmi Doğu; Aydan Akdeniz; Ali Ünal; Ahmet Seyhanlı; Emel Gürkan; Demet Çekdemir; Burhan Ferhanoğlu
Journal:  Turk J Haematol       Date:  2021-08-27       Impact factor: 1.831

2.  The CLL comorbidity index in a population-based cohort: a tool for clinical care and research.

Authors:  Emelie C Rotbain; Max J Gordon; Noomi Vainer; Henrik Frederiksen; Henrik Hjalgrim; Alexey V Danilov; Carsten U Niemann
Journal:  Blood Adv       Date:  2022-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.